[go: up one dir, main page]

HK1100064A - 使用性腺类固醇功能调节剂治理创伤及纤维化疾病 - Google Patents

使用性腺类固醇功能调节剂治理创伤及纤维化疾病 Download PDF

Info

Publication number
HK1100064A
HK1100064A HK07107548.5A HK07107548A HK1100064A HK 1100064 A HK1100064 A HK 1100064A HK 07107548 A HK07107548 A HK 07107548A HK 1100064 A HK1100064 A HK 1100064A
Authority
HK
Hong Kong
Prior art keywords
wound
oestrogen
wounds
compound
scarring
Prior art date
Application number
HK07107548.5A
Other languages
English (en)
Inventor
Mark William James Ferguson
Gillian Sarah Ashcroft
Original Assignee
Renovo Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Limited filed Critical Renovo Limited
Publication of HK1100064A publication Critical patent/HK1100064A/zh

Links

HK07107548.5A 1996-07-22 2005-03-04 使用性腺类固醇功能调节剂治理创伤及纤维化疾病 HK1100064A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9615348 1996-07-22
GB9701600 1997-01-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK05101888.8A Addition HK1069114A (zh) 1996-07-22 2005-03-04 应用性类固醇功能调节剂治疗创伤和纤维变性疾病

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK05101888.8A Division HK1069114A (zh) 1996-07-22 2005-03-04 应用性类固醇功能调节剂治疗创伤和纤维变性疾病

Publications (1)

Publication Number Publication Date
HK1100064A true HK1100064A (zh) 2007-09-07

Family

ID=

Similar Documents

Publication Publication Date Title
US6696433B2 (en) Use of sex steroids function modulators to treat wounds and fibrotic disorders
Ashcroft et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response
Simoncini et al. Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase
Frazier-Jessen et al. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages.
US4310523A (en) Combined antiestrogens and antigonadotropically effective antiandrogens for the prophylaxis and therapy of hyperplasia of the prostate
CA2394165C (en) Drospirenone for hormone replacement therapy
EP1003522B1 (en) Use of estrogen for preventing or controlling cataract
US20040009960A1 (en) Drospirenone for hormone replacement therapy
ES2643318T3 (es) Composiciones y métodos para suprimir la proliferación endometrial
EP0844884A2 (en) Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of uterine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and for hormone replacement therapy
WO2002080906A1 (en) Prevention and treatment of endometriosis with aryl hydrocarbon receptor binding ligands
KR100434238B1 (ko) 경관팽창및신장조절을위한산화질소공여체또는산화질소억제제의용도
AU755438B2 (en) Use of sex steroid function modulators to treat wounds and fibrotic disorders
HK1100064A (zh) 使用性腺类固醇功能调节剂治理创伤及纤维化疾病
HK1069114A (zh) 应用性类固醇功能调节剂治疗创伤和纤维变性疾病
HK1021319B (zh) 一种化合物之应用以提升雌激素活动来治疗创伤
Menchini et al. Epidermolysis bullosa
JPH11501648A (ja) 男性の生殖能を調節するための抗エストロゲンの使用
MXPA97008577A (en) Endothelin antagonists and inhibitors of endothelin synthesis for the prevention and treatment of uterine contractility disorders, preeclampsia, vascular aterosclerotic diseases, hypertension and for replacement therapy